MeiraGTx Holdings (MGTX) Total Current Liabilities (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Total Current Liabilities came in at $283000.0 in Q4 2025, down 68.66% YoY from $903000.0 in Q4 2024, and down 99.81% on a QoQ basis from $152.9 million in Q3 2025.
MeiraGTx Holdings (MGTX) Total Current Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Total Current Liabilities data on file, last reported at $283000.0 in Q4 2025.
- Quarterly Total Current Liabilities fell 68.66% year-over-year to $283000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283000.0 (down 68.66% YoY) and the FY2025 annual result came in at $283000.0, down 68.66% from the prior year.
- Total Current Liabilities fell to $283000.0 in Q4 2025, from $152.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $152.9 million in Q3 2025 to a low of $283000.0 in Q4 2025.
- A 5-year average of $61.2 million and a median of $61.6 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities tumbled 98.65% — and 2025, when it soared 157.37%.
- Tracing MGTX's Total Current Liabilities over 5 years: stood at $68.1 million in 2021, then rose by 20.47% to $82.1 million in 2022, then decreased by 18.27% to $67.1 million in 2023, then plunged by 98.65% to $903000.0 in 2024, then tumbled by 68.66% to $283000.0 in 2025.
- The last three Total Current Liabilities figures came in at $283000.0 (Q4 2025), $152.9 million (Q3 2025), and $53.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 283,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 152.92 Mn |
| Jun 30, 2025 | 53.44 Mn |
| Mar 31, 2025 | 52.37 Mn |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 59.42 Mn |
| Jun 30, 2024 | 47.01 Mn |
| Mar 31, 2024 | 47.54 Mn |
| Dec 31, 2023 | 67.08 Mn |
| Sep 30, 2023 | 63.51 Mn |
| Jun 30, 2023 | 71.80 Mn |
| Mar 31, 2023 | 81.10 Mn |
| Dec 31, 2022 | 82.07 Mn |
| Sep 30, 2022 | 72.36 Mn |
| Jun 30, 2022 | 67.51 Mn |
| Mar 31, 2022 | 65.50 Mn |
| Dec 31, 2021 | 68.13 Mn |
| Sep 30, 2021 | 59.63 Mn |
| Jun 30, 2021 | 57.25 Mn |
| Mar 31, 2021 | 53.52 Mn |